INTRODUCTION
Cystic fi brosis (CF) is a chronic and progressive autosomal recessive genetic disease that affects various organs and systems of the body 1 . According to the Cystic Fibrosis Foundation, approximately 70 thousand persons in the world have CF. 2 In Brazil, the most recent data of the Brazilian Register of Cystic Fibrosis (REBRAFC), accounted for approximately 4 thousand patients. 3 Celiac disease (CD) is a systemic disease mediated by permanent susceptibility to gluten, triggered by autoimmune mechanisms in genetically predisposed individuals. 1 The prevalence of CD is estimated at around 1% of the population worldwide. 4 CF and CD were recognized as a single clinical entity for many years, since the intestinal malabsorption syndrome occurs in both 5 , and the clinical manifestations of the diseases may be similar, which contributed to the diffi culty in distinguishing between the two illnesses in the past 6 .
At present there are specifi c diagnostic methods for each disease. According to the Guidelines of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN, 2012) , in patients with gluten-dependent symptoms, the diagnosis of CD may be confi rmed by elevation in the levels of antibodies specifi c for CD and the presence of alleles HLA-DQ2/DQ8, which may eliminate the need to perform intestinal biopsy in these cases. Histopathological exam must be performed when the above mentioned studies are not available. 7 As criteria for the diagnosis of CF, the Cystic Fibrosis Foundation Consensus Panel established the presence of a phenotypical clinical condition or family history of CF, or positive newborn screening associated with the elevation of chloride concentration in sweat or identifi cation of two mutations of CFTR; or in vivo demonstration of nasal epithelial ion transport abnormalities. 8 As reported by Genkova (2013) , the sweat test may be false positive in the presence of the malabsorption syndrome 9 which may raise doubts as regards diagnosis between the two diseases. This emphasizes the importance of careful clinical observation in medical practice. The possibility of diagnostic confusion between these diseases may delay the adequate treatment of each disease. This report describes two patients with initial diagnosis of cystic fi brosis who received diagnostic confi rmation of CD during follow-up, therefore the diagnosis of CF was excluded. The free and informed consent of the persons responsible for the patients was obtained in the preparation for this study.
CASE REPORT 1
The 
Exam Result
High digestive endoscopy Duodenum with ample and distensible bulb, mucosa with normal aspect, in addition to mucosa with whitened aspect, with pavementlike pattern, with apparent reduction of the folds and villi in the second portion of the duodenum, with the aspect being suggestive of celiac disease. disease with characteristics similar to those of CD. In fact, the intestinal malabsorption syndrome occurs in both, 11 and the sweat test may be falsely positive in the presence of the malabsorption syndrome. 9 This may lead to doubtful diagnoses between the two diseases and should alert the doctor to make a judicious diagnosis of the two conditions. Both patients described initially presented two positive sweat tests. The fi rst report concerning a patient in a severe state of malnutrition, which could elevate chlorine levels in sweat, was made by Mace et al (1971) . 12 However, in spite of the description of chlorine level elevation in the sweat of undernourished patient, in comparison with eutrophic children, these are not expected to attain values compatible with those in CF. 12 The development of Case 1 suggested that in addition to CD, malnutrition may have contributed to elevation of chlorine in the sweat, since the exam showed normality after the improvement in nutrition and exclusion of gluten from the diet.
In the report on Case 2, the history of abdominal distension associated with the ingestion (WHO, 2006) . 10 The last sweat test performed was negative (chlorine = 27 and 24 mEq/L).
The main exams the patient underwent are shown in Table 2 .
In Fig. 3 , the findings of the pathological anatomy are presented, showing chronic duodenitis with intense villus atrophy and intra-epithelial lymphocytosis.
DISCUSSION
CF was initially described in 1938, when pancreatic fi brosis was noted in the necropsies of patients clinically diagnosed with celiac syndrome. 5 CF is a of gluten-containing foods drew attention, and led to the suspicion of CD and the possibility of the sweat test being falsely positive. Normalization of the exam after excluding gluten from the diet corroborated the initial clinical impression and highlighted CD among the different clinical conditions that may accompany elevations of electrolytes in the sweat. 13 The two patients herein reported were submitted to intestinal biopsy for diagnostic confi rmation, because research of the HLA-DQ2/ DQ8 alleles is not available at the center where they were treated. As execution of allele exams is restricted to more developed centers, this justifi ed the use of a more invasive exam to confi rm the diagnosis of CD.
On the other hand, association between these two diseases has been reported; however, their coexistence in one and the same individual has been described as a casual fi nding. 11 Some authors have discussed the hypothesis of a non-casual link between them, making diagnosis of the two diseases more challenging. 11,
The frequency of being simultaneously affected by the two pathologies is unknown, but it has been estimated that the incidence of CD among patients with CF varies between 1:87 to 1:373. 6 In 2009, Fluge et al. conducted a multicentric study, performing screening for CD in patients with CF, and found a prevalence of 1.2%. 11 Diagnosis of CF in patients with CD has also been described. In 1999, Venuta et al. described a 14-month-old patient with chronic diarrhea, recurrent respiratory infections and growth defi cit, who had a confi rmed diagnosis of CD. The child developed with poor clinical response to the restriction of gluten in the diet. Later diagnostic investigation confi rmed CF, revealing an association between the two diseases. 14 There is no consensus in the literature about when to investigate CD in patients with CF. Genkova et al. (2013) suggested investigation in all patients with CF that present the following clinical manifestations: intestinal malabsorption without improvement with standard treatment, delay in neuro-psychomotor development, co-morbidity that predisposes to autoimmune phenomena (diabetes mellitus type 1, juvenile idiopathic arthritis, autoimmune thyroiditis, Down syndrome), persistent anemia ferropriva, fi rst episode of hypoprothrombinemia or any other sign of hepatic involvement. 9 In the cases herein related, research for CD was performed due to poor response to treatment in the fi rst case, and due to the clinical history suggestive of CD in the second case.
These case reports emphasize the possibility of the sweat test being falsely positive in CD, which may confound the medical conduct of the case, delaying diagnosis and adequate treatment of this disease. However, the possibility of coexistence between the two diseases must also be borne in mind. Pediatricians must consider the investigation of CD in patients with CF, who do not present with good weight-height development, or have poor control of symptoms of malabsorption in spite of receiving adequate therapy.
CONCLUSIONS
These case reports emphasize the possibility of the sweat test being falsely positive in CD, which may confound the medical conduct of the case thus delaying diagnosis and adequate treatment of this disease. However, the possibility of coexistence between the two diseases must also be borne in mind. Pediatricians must consider the investigation of CD in patients with CF that do not present with good weight-height development, or have poor control of symptoms of malabsorption in spite of receiving adequate therapy.
